Roivant Sciences Ltd.
SEC-identified person · CIK 1635088 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Immunovant, Inc. IMVT | Director | filed 2019 - 2025 |
| Tekmira Pharmaceuticals Corp TKMR | Officer | filed 2015 - 2021 |
| Sio Gene Therapies Inc. SIOX | Officer | filed 2015 - 2020 |
| Myovant Sciences Ltd. MYOV | Officer | filed 2016 - 2019 |
| Urovant Sciences Ltd. UROV | Officer | filed 2018 - 2019 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.